HC Surgical Specialists : Sustainability Report FY2022 Download

Board Statement --------------------------------------------------------	1
About this Report -------------------------------------------------------	2
About the Group --------------------------------------------------------	3
Our Sustainability Approach ---------------------------------------	5
Our Stakeholders -------------------------------------------------------	7
Material Topics -----------------------------------------------------------	8
Economic Performance ----------------------------------------------	9
Waste and Effluents --------------------------------------------------	11
Employment ------------------------------------------------------------	13
Patients Privacy --------------------------------------------------------	16
GRI Content Index ----------------------------------------------------	17

Dear Stakeholders,

On behalf of the Board of Directors (the "Board") and the Management of HC Surgical Specialists Limited ("HCSS", and together with its subsidiaries, the "Group"), I am pleased to present our fifth annual Sustainability Report (the "Report") for the financial year ended 31 May 2022 ("FY2022"). This Report underscores our continuous commitment to reaffirming the importance of environmental, social and governance ("ESG") topics in every aspect of our business operations. Not only do these issues speak to who we are as a company, but they also matter greatly to our stakeholders.

FY2022 marks the year when we learned to live with the COVID-19 virus. As an organisation deeply involved in the health of our patients, we do not envision returning to pre-pandemic days but rather, finding new ways to promote a full and healthy life amidst the pandemic. For the Group, this means actively responding to our stakeholders' concerns and progressively developing a strong and resilient healthcare system that can withstand the pressures of future disease outbreaks. Even as the Group continues to grow and expand, our patients' well-being will always be our utmost priority.

The Board plays an instrumental role in guiding and overseeing our Group's sustainability strategy and efforts. Working closely with senior management, the Board takes the lead in determining ESG factors that are material to the Group's business and our stakeholders and provide oversight over the management and monitoring of these factors. Taking steps to identify and address a wide range of material sustainability issues, HCSS is well prepared to face any challenges and risks that lie ahead.

We would hereby like to express our heartfelt appreciation to all our stakeholders for joining us in our sustainability journey. With your continued trust and support, we are confident that HCSS will continue to flourish.

Mr. Chong Weng Hoe

Non-Executive Chairman and Independent Director

1

Our Sustainability Report for FY2022 provides a broad overview of the Group's sustainability strategies, initiatives, and performance from 1 June 2021 to 31 May 2022, and should be read in conjunction with HCSS's Annual Report 2022.

This Report has been prepared in compliance with Rules 711A and 711B of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist (the "Catalist Rules"), with reference to the guidelines set out in SGX-ST's Practice Note 7F Sustainability Reporting Guide.

This Report has also been prepared in accordance with the Global Reporting Initiative ("GRI") Standards - Core Option, which continues to be our sustainability reporting framework of choice given how it is internally recognised, widely adopted and well-suited to our business model. In defining the contents of this Report, the Group has applied the recommended GRI principles of stakeholder inclusiveness, sustainability context, materiality, and completeness, as follows:

	Materiality			Stakeholder Inclusiveness
	Focusing on the issues that impact			Responding to stakeholders' expectations
	business growth and are of utmost
			and interests
	importance to stakeholders
	Sustainability Context			Completeness
	Presenting performance in the wider			Including information on all significant ESG
			impacts to enable stakeholders to assess
	context of sustainability
			HCSS's performance

We have relied on internal verification to ensure the accuracy of the data and information reported and will consider seeking external independent assurance at a later stage of our sustainability reporting journey. In the meantime, we will continue to improve upon our data collection and reporting practices.

As part of our environmental conservation efforts, we will not be printing our Sustainability Report. The electronic edition of this report will be made available for download from our website at https://www.hcsurgicalspecialists.com/and SGX-ST's website, at www.sgx.com.

We are fully committed to listening to our stakeholders, and we welcome all feedback and suggestions on the contents of this Report at [e-mail].

2

Starting out almost a decade ago, HCSS's vision is to build an organisation dedicated to making private healthcare accessible to the broadest consumer base possible, and we view it as our mission to bring healthcare to our patients' doorsteps.

While HCSS is a medical services group primarily engaged in the provision of endoscopic procedures (including gastroscopies and colonoscopies to treat conditions of the digestive system), we do also offer general diagnostic and consultation services to our patients. Most of our clinics are equipped with the facilities to perform general surgery services, with a focus on colorectal surgery, and our team of doctors is broadly capable of performing any surgical or medical procedure. Patients who prefer accessing medical care from the comfort of their homes can opt for our house call services as well.

Though two of our clinics, HC Thyroid Hernia & General Surgery Centre and The GP Endoscopy & Piles Centre (Dleedon) were closed in October 2021, we continue to operate a network of 16 clinics and endoscopy centres located throughout Singapore.

Our endoscopy clinics are also Medisave and Medishield Life accredited, enabling us to enhance the services offered to our patients.

As a public company limited by shares, our registered office is located at 80 Robinson Road, #02-00, Singapore 068898.

3